180 related articles for article (PubMed ID: 23420560)
1. Tumour cell survival mechanisms in lethal metastatic prostate cancer differ between bone and soft tissue metastases.
Akfirat C; Zhang X; Ventura A; Berel D; Colangelo ME; Miranti CK; Krajewska M; Reed JC; Higano CS; True LD; Vessella RL; Morrissey C; Knudsen BS
J Pathol; 2013 Jul; 230(3):291-7. PubMed ID: 23420560
[TBL] [Abstract][Full Text] [Related]
2. A novel antisense oligonucleotide inhibiting several antiapoptotic Bcl-2 family members induces apoptosis and enhances chemosensitivity in androgen-independent human prostate cancer PC3 cells.
Yamanaka K; Rocchi P; Miyake H; Fazli L; Vessella B; Zangemeister-Wittke U; Gleave ME
Mol Cancer Ther; 2005 Nov; 4(11):1689-98. PubMed ID: 16275990
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers.
Krajewska M; Krajewski S; Epstein JI; Shabaik A; Sauvageot J; Song K; Kitada S; Reed JC
Am J Pathol; 1996 May; 148(5):1567-76. PubMed ID: 8623925
[TBL] [Abstract][Full Text] [Related]
4. [Expression of survivin in patients with acute myeloid leukemia].
Sun WX; Zhang PH; Fang LH; Tian Z; Tang KJ; Rao Q; Wang M; Wang JX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1099-104. PubMed ID: 24156414
[TBL] [Abstract][Full Text] [Related]
5. Expression of CXCR4, E-cadherin, Bcl-2, and survivin in Merkel cell carcinoma: an immunohistochemical study using a tissue microarray.
Knapp CF; Sayegh Z; Schell MJ; Rawal B; Ochoa T; Sondak VK; Messina JL
Am J Dermatopathol; 2012 Aug; 34(6):592-6. PubMed ID: 22814318
[TBL] [Abstract][Full Text] [Related]
6. Dickkopf-1 expression increases early in prostate cancer development and decreases during progression from primary tumor to metastasis.
Hall CL; Daignault SD; Shah RB; Pienta KJ; Keller ET
Prostate; 2008 Sep; 68(13):1396-404. PubMed ID: 18561248
[TBL] [Abstract][Full Text] [Related]
7. Mcl-1, Bcl-XL and Stat3 expression are associated with progression of melanoma whereas Bcl-2, AP-2 and MITF levels decrease during progression of melanoma.
Zhuang L; Lee CS; Scolyer RA; McCarthy SW; Zhang XD; Thompson JF; Hersey P
Mod Pathol; 2007 Apr; 20(4):416-26. PubMed ID: 17384650
[TBL] [Abstract][Full Text] [Related]
8. The downregulation of Mcl-1 via USP9X inhibition sensitizes solid tumors to Bcl-xl inhibition.
Peddaboina C; Jupiter D; Fletcher S; Yap JL; Rai A; Tobin RP; Jiang W; Rascoe P; Rogers MK; Smythe WR; Cao X
BMC Cancer; 2012 Nov; 12():541. PubMed ID: 23171055
[TBL] [Abstract][Full Text] [Related]
9. The dual PI3K/mTOR inhibitor NVP-BGT226 induces cell cycle arrest and regulates Survivin gene expression in human pancreatic cancer cell lines.
Glienke W; Maute L; Wicht J; Bergmann L
Tumour Biol; 2012 Jun; 33(3):757-65. PubMed ID: 22170433
[TBL] [Abstract][Full Text] [Related]
10. Oleanane triterpenoid CDDO-Me induces apoptosis in multidrug resistant osteosarcoma cells through inhibition of Stat3 pathway.
Ryu K; Susa M; Choy E; Yang C; Hornicek FJ; Mankin HJ; Duan Z
BMC Cancer; 2010 May; 10():187. PubMed ID: 20459702
[TBL] [Abstract][Full Text] [Related]
11. Functional and biological analysis of Bcl-xL expression in human osteosarcoma.
Wang ZX; Yang JS; Pan X; Wang JR; Li J; Yin YM; De W
Bone; 2010 Aug; 47(2):445-54. PubMed ID: 20580954
[TBL] [Abstract][Full Text] [Related]
12. STAT3 mRNA and protein expression in colorectal cancer: effects on STAT3-inducible targets linked to cell survival and proliferation.
Lassmann S; Schuster I; Walch A; Göbel H; Jütting U; Makowiec F; Hopt U; Werner M
J Clin Pathol; 2007 Feb; 60(2):173-9. PubMed ID: 17264243
[TBL] [Abstract][Full Text] [Related]
13. Survivin and Bcl-2 expression in prostatic adenocarcinomas.
Kaur P; Kallakury BS; Sheehan CE; Fisher HA; Kaufman RP; Ross JS
Arch Pathol Lab Med; 2004 Jan; 128(1):39-43. PubMed ID: 14692814
[TBL] [Abstract][Full Text] [Related]
14. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
15. Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer.
Gazzaniga P; Gradilone A; Giuliani L; Gandini O; Silvestri I; Nofroni I; Saccani G; Frati L; Aglianò AM
Ann Oncol; 2003 Jan; 14(1):85-90. PubMed ID: 12488298
[TBL] [Abstract][Full Text] [Related]
16. Sabutoclax, a Mcl-1 antagonist, inhibits tumorigenesis in transgenic mouse and human xenograft models of prostate cancer.
Jackson RS; Placzek W; Fernandez A; Ziaee S; Chu CY; Wei J; Stebbins J; Kitada S; Fritz G; Reed JC; Chung LW; Pellecchia M; Bhowmick NA
Neoplasia; 2012 Jul; 14(7):656-65. PubMed ID: 22904682
[TBL] [Abstract][Full Text] [Related]
17. Keratin 13 expression reprograms bone and brain metastases of human prostate cancer cells.
Li Q; Yin L; Jones LW; Chu GC; Wu JB; Huang JM; Li Q; You S; Kim J; Lu YT; Mrdenovic S; Wang R; Freeman MR; Garraway I; Lewis MS; Chung LW; Zhau HE
Oncotarget; 2016 Dec; 7(51):84645-84657. PubMed ID: 27835867
[TBL] [Abstract][Full Text] [Related]
18. Subcellular Compartmentalization of Survivin is Associated with Biological Aggressiveness and Prognosis in Prostate Cancer.
Hennigs JK; Minner S; Tennstedt P; Löser R; Huland H; Klose H; Graefen M; Schlomm T; Sauter G; Bokemeyer C; Honecker F
Sci Rep; 2020 Feb; 10(1):3250. PubMed ID: 32094363
[TBL] [Abstract][Full Text] [Related]
19. Dual inhibition of Bcl-2 and Bcl-xL strikingly enhances PI3K inhibition-induced apoptosis in human myeloid leukemia cells through a GSK3- and Bim-dependent mechanism.
Rahmani M; Aust MM; Attkisson E; Williams DC; Ferreira-Gonzalez A; Grant S
Cancer Res; 2013 Feb; 73(4):1340-51. PubMed ID: 23243017
[TBL] [Abstract][Full Text] [Related]
20. Significance of survivin and Bcl-2 homologous antagonist/killer mRNA in detection of bone metastasis in patients with breast cancer.
Zohny SF; El-Shinawi M
Med Oncol; 2011 Dec; 28 Suppl 1():S108-14. PubMed ID: 20978950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
